Biophysical Assays Science Small Molecule 
Drug Target Review
NOVEMBER 1, 2023
The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. We have several exciting projects in various stages of discovery, but a small-molecule drug that is causing a lot of excitement at the moment is Capivasertib.
Drug Discovery World
AUGUST 9, 2024
Self-assembled monolayers in high-density biochip arrays Zachary Gurard-Levin, PhD, Science Director, Discovery, Charles River says that: “Historically, MS instruments have not always been amenable to the components required for optimal activity in a biochemical or binding reaction. The company also makes Orbitrap-based LC-MS instruments.
Expert insights. Personalized for you.
96 
Let's personalize your content